This is a news story, published by ABC News, that relates primarily to Anne Wojcicki news.
For more Anne Wojcicki news, you can click here:
more Anne Wojcicki newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from ABC News, you can click here:
more news from ABC NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
23andMe CEO. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest 23andMe news, latest restructuring efforts news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
genetic testing companyABC News
•
83% Informative
23andMe is laying off 40% of its workforce and discontinuing its therapeutics division.
The company said it plans to wind down ongoing clinical trials “as quickly as practical” The company is evaluating “strategic alternatives” for assets related to its drug development and research programs.
CEO Anne Wojcicki said the company was "taking these difficult but necessary actions".
VR Score
85
Informative language
84
Neutral language
74
Article tone
semi-formal
Language
English
Language complexity
52
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
4
Source diversity
1
Affiliate links
no affiliate links